AI Article Synopsis

  • This study analyzed how the MELD-XI score affects outcomes for patients undergoing elective coronary artery bypass surgery (CABG), with or without cardiopulmonary bypass.
  • The research included 3,535 patients and found that those with MELD-XI scores above 11 had significantly higher in-hospital mortality rates (6.2%) compared to those below (1.5%).
  • The findings suggest that higher MELD-XI scores, along with factors like the type of surgery and pre-existing conditions, can independently predict increased mortality risk in CABG patients.

Article Abstract

Background:  This study aimed to assess the influence of the model of end-stage liver disease without International Normalized Ratio (INR) (MELD-XI) score on outcomes after elective coronary artery bypass surgery (CABG) without (Off-Pump) or with (On-Pump) cardiopulmonary bypass.

Methods:  We calculated MELD-XI (5.11 × ln serum bilirubin + 11.76 × ln serum creatinine in + 9.44) for 3,535 consecutive patients having undergone elective CABG between 2009 and 2020. A MELD-XI threshold was determined using the Youden Index based on receiver operating characteristics. Propensity score matching and logistic regression was performed to identify risk factors for inhospital mortality and Major Adverse Cardiac and Cerebrovascular Event (MACCE).

Results:  Patients were 68 ± 10 years old (76% male). Average MELD-XI was 10.9 ± 3.25. The MELD-XI threshold was 11. Patients below this threshold had somewhat lower EuroSCORE II than those above (3.5 ± 4 vs. 4.1 ± 4.7,  < 0.01), but mortality was almost four times higher above the threshold (below 1.5% vs. above 6.2%,  < 0.001). Two-thirds of patients received Off-Pump CABG. There was a trend towards higher risk in Off-Pump patients. Mortality was numerically but not statistically different to On-Pump below the MELD XI threshold (1.3 vs. 2.2%,  = 0.34) and was significantly lower above the threshold (4.9 vs. 8.9%,  < 0.02). Off-Pump above the threshold was also associated with less low-output syndrome and fewer strokes. Equalizing baseline differences by propensity matching verified the significant mortality difference above the threshold. Multivariable regression analysis revealed MELD-XI, On-Pump, atrial fibrillation, and the De Ritis quotient (Aspartate aminotransferase (ASAT)/Alanine Aminotransferase (ALAT)) as independent predictors of mortality.

Conclusion:  Elective CABG patients with elevated MELD-XI scores are at increased risk for perioperative mortality and morbidity. This risk can be significantly mitigated by performing CABG Off-Pump.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0044-1786039DOI Listing

Publication Analysis

Top Keywords

meld-xi score
8
meld-xi threshold
8
meld-xi
6
off-pump reduces
4
reduces risk
4
risk coronary
4
coronary bypass
4
bypass grafting
4
grafting patients
4
patients high
4

Similar Publications

Aims: Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end-stage liver disease (MELD) score and its variations in predicting adverse outcomes [death, urgent heart transplant, and left ventricular assist device (LVAD) implant] among patients with AHF to assess the clinical associations of the MELD score in this population and to compare the efficacy of this tool with other prognostic scores in AHF.

Methods And Results: In this longitudinal prospective study, 162 patients with advanced heart failure (AHF) were enrolled; all patients included in the study were receiving the maximum tolerated medical therapy according to guidelines.

View Article and Find Full Text PDF

Clinical impact of circulating biomarkers in prediction of adverse cardiac events in patients with congenital heart disease. A systematic review.

Int J Cardiol

November 2024

Department of Paediatrics, Division of Paediatric Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands; Cardiology Expert Group of the connect4children (c4c) network. Electronic address:

Introduction: Patients with congenital heart disease (ConHD) are at increased risk for adverse cardiac events. Predicting long-term outcomes and guidance of patient management might benefit from a range of (new) biomarkers. This is a rapidly evolving field with potentially large consequences for clinical decision making.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how well right ventricular free wall longitudinal strain can predict peri-operative mortality in patients with severe tricuspid regurgitation undergoing tricuspid valve surgery, compared to traditional risk scores.
  • Researchers analyzed data from 110 patients, ultimately focusing on 79 who met criteria, finding that 9% died within 30 days post-surgery.
  • Results showed that right ventricular free wall longitudinal strain was the strongest predictor of mortality, outperforming classic risk scores when combined, indicating its potential importance in patient assessment before surgery.*
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on older patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis, emphasizing the need for better risk assessment tools due to multiple comorbidities.
  • Researchers developed a new risk score, the 3C score, based on various cardiac and noncardiac factors to predict two-year all-cause mortality in these patients.
  • Results showed that the 3C score was more effective in predicting mortality compared to established scoring systems like the Charlson Comorbidities Index and EuroSCORE II, highlighting its potential for better risk stratification in older adults undergoing TAVR.
View Article and Find Full Text PDF
Article Synopsis
  • The TRILUMINATE Pivotal trial investigated the impact of tricuspid regurgitation (TR) on end-organ function and the effectiveness of transcatheter edge-to-edge repair (TEER) compared to medical therapy alone in patients with severe TR.
  • The study included 572 patients who were split into TEER and control groups, examining how changes in end-organ function correlate with hospitalizations for heart failure (HF) and mortality over 12 months.
  • Results showed that while TEER did not significantly differ from medical therapy alone in overall end-organ function improvements, successful TEER did lead to enhanced function in specific patient subgroups, indicating potential benefits in targeted treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!